tiprankstipranks
Trending News
More News >
Seres Therapeutics (DE:1S90)
FRANKFURT:1S90
Germany Market
Advertisement

Seres Therapeutics (1S90) Technical Analysis

Compare
1 Followers

Summary of all the Indicators

Overall Consensus
Strong Buy
15Bullish
2Neutral
4Bearish
Technical Analysis Consensus
Sell
3Bullish
2Neutral
4Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Seres Therapeutics’s (1S90) Moving Averages Convergence Divergence (MACD) indicator is 2.07, suggesting Seres Therapeutics is a Buy.
Seres Therapeutics’s (1S90) 20-Day exponential moving average is 11.19, while Seres Therapeutics’s (1S90) share price is €14, making it a Buy.
Seres Therapeutics’s (1S90) 50-Day exponential moving average is 7.87, while Seres Therapeutics’s (1S90) share price is €14, making it a Buy.

Seres Therapeutics (1S90) Pivot Points

Aug 15, 2025, 05:09 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
12.48
12.70
13.14
13.36
13.80
14.02
14.46
Fibonacci
12.70
12.95
13.11
13.36
13.61
13.77
14.02
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Seres Therapeutics (1S90) Moving Averages

Aug 15, 2025, 05:09 PM
Period
Simple
Exponential
MA5
13.04Buy
13.16Buy
MA10
12.51Buy
12.60Buy
MA20
12.08Buy
11.19Buy
MA50
5.68Buy
7.87Buy
MA100
4.76Buy
7.16Buy
MA200
9.90Buy
9.93Buy
Seres Therapeutics’s (1S90) 10-Day exponential moving average is 12.60, while Seres Therapeutics’s (1S90) share price is €14, making it a Buy.
Seres Therapeutics’s (1S90) 100-Day exponential moving average is 7.16, while Seres Therapeutics’s (1S90) share price is €14, making it a Buy.
Seres Therapeutics’s (1S90) stock price is €14 and Seres Therapeutics’s (1S90) 50-day simple moving average is 5.68, creating a Buy signal.
Seres Therapeutics’s (1S90) stock price is €14 and Seres Therapeutics’s (1S90) 100-day simple moving average is 4.76, creating a Buy signal.
Seres Therapeutics’s (1S90) stock price is €14 and Seres Therapeutics’s (1S90) 200-day simple moving average is 9.90, creating a Buy signal.

Seres Therapeutics (1S90) Technical Indicators

Aug 15, 2025, 05:09 PM
Name
Value
Implied Action
RSI (14)
72.63
Sell
STOCH (9,6)
92.54
Sell
STOCHRSI (14)
95.76
Sell
MACD (12,26)
2.07
Buy
ADX (14)
23.88
Neutral
Williams %R
0.00
Sell
CCI (14)
213.99
Sell
ATR (14)
9.03
-
Ultimate Oscillator
59.72
Neutral
ROC
22.16
Buy
Seres Therapeutics’s (1S90) Relative Strength Index (RSI) is 72.63, creating a Sell signal.
Seres Therapeutics’s (1S90) Trend Strength Indicator (ADX) is 23.88, creating a Neutral signal.
Seres Therapeutics’s (1S90) Commodity Channel Index (CCI) is 213.99, creating a Sell signal.
Seres Therapeutics’s (1S90) Price Rate of Change (ROC) is 22.16, creating a Buy signal.

FAQ

Is 1S90 a Buy, Hold, or Sell?
Based on 1S90’s technical indicators, 1S90 is a Strong Buy.
    What is 1S90’s RSI (14)?
    1S90’s RSI (14) is 72.63, which suggests 1S90 is a Sell.
      What is 1S90’s MACD?
      1S90’s MACD is 2.07, which suggests 1S90 is a Buy.
        What is 1S90’s 5-day moving average?
        1S90’s 5-day moving average is 13.04, which suggests 1S90 is a Buy.
          What is 1S90’s 20-day moving average?
          1S90 20-day moving average is 12.08, which suggests 1S90 is a Buy.
            What is 1S90’s 50-day moving average?
            1S90’s 50-day moving average is 5.68, which suggests 1S90 is a Buy.
              What is 1S90’s 200-day moving average?
              1S90’s 200-day moving average is 9.90, which suggests 1S90 is a Buy.
                What is 1S90’s Williams % R (14)?
                1S90’s Williams % R (14) is 0.00, which suggests 1S90 is a Sell.
                  What is 1S90’s CCI (14)?
                  1S90’s CCI (14) is 213.99, which suggests 1S90 is a Sell.
                    What is the share price of Seres Therapeutics?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis